These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2533949

  • 1. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y, Schneider MR, Michna H, el Etreby MF.
    J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M, Yano S, Hasegawa Y, Nakao K.
    Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y, Sugamata N, Owada S, Tago T, Sato H, Yokoe T, Maemura M, Morishita Y, Horiuchi R.
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y, Karakida T, Sugamata N, Andoh T, Takei H, Takahashi M, Yaguchi S, Matsuno T, Takehara M, Sakato M, Kawashima S, Morishita Y.
    Anticancer Res; 1998 Jun; 18(1A):171-6. PubMed ID: 9568073
    [Abstract] [Full Text] [Related]

  • 7. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.
    Schieweck K, Bhatnagar AS, Batzl C, Lang M.
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):633-6. PubMed ID: 8476774
    [Abstract] [Full Text] [Related]

  • 8. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ.
    J Steroid Biochem; 1989 Mar; 34(1-6):439-42. PubMed ID: 2516585
    [Abstract] [Full Text] [Related]

  • 9. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
    Bhatnagar AS, Häusler A, Schieweck K, Lang M, Bowman R.
    J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):1021-7. PubMed ID: 2149502
    [Abstract] [Full Text] [Related]

  • 10. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Zaccheo T, Giudici D, Lombardi P, di Salle E.
    Cancer Chemother Pharmacol; 1989 Dec 20; 23(1):47-50. PubMed ID: 2491793
    [Abstract] [Full Text] [Related]

  • 11. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
    Tekmal RR, Durgam VR.
    Cancer Lett; 1997 Sep 16; 118(1):21-8. PubMed ID: 9310256
    [Abstract] [Full Text] [Related]

  • 12. Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.
    Houjou T, Wada T, Yasutomi M.
    Clin Ther; 1993 Sep 16; 15(1):137-47. PubMed ID: 8458043
    [Abstract] [Full Text] [Related]

  • 13. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E, Briatico G, Giudici D, Ornati G, Zaccheo T.
    J Steroid Biochem; 1989 Sep 16; 34(1-6):431-4. PubMed ID: 2516584
    [Abstract] [Full Text] [Related]

  • 14. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
    el Etreby MF.
    J Steroid Biochem Mol Biol; 1993 Mar 16; 44(4-6):565-72. PubMed ID: 7682838
    [Abstract] [Full Text] [Related]

  • 15. Novel aromatase inhibitors.
    Bhatnagar AS, Häusler A, Schieweck K, Browne LJ, Bowman R, Steele RE.
    J Steroid Biochem Mol Biol; 1990 Nov 20; 37(3):363-7. PubMed ID: 2147860
    [Abstract] [Full Text] [Related]

  • 16. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
    Tominaga T, Yoshida Y, Shimozuma K, Hayashi K, Kosaki G.
    Eur J Cancer; 1990 Nov 20; 26(5):600-3. PubMed ID: 2144748
    [Abstract] [Full Text] [Related]

  • 17. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T, Di Salle E.
    Cancer Chemother Pharmacol; 1989 Nov 20; 25(2):95-8. PubMed ID: 2513137
    [Abstract] [Full Text] [Related]

  • 18. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
    Zhou JL, Brodie A.
    J Steroid Biochem Mol Biol; 1995 Jan 20; 52(1):71-6. PubMed ID: 7857875
    [Abstract] [Full Text] [Related]

  • 19. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH.
    Cancer Res; 1982 Aug 20; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.